X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%
Mon, 27 May

ASTRAZENECA PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m1,5072,1521,903-11.6%26.3%
Other incomeRs m23356072.0%157.1%
TurnoverRs m1,5312,1871,963-10.2%28.3%
ExpensesRs m1,3551,7431,8395.5%35.8%
Gross profitRs m15340964-84.4%-58.3%
DepreciationRs m3638393.4%10.1%
InterestRs m0000.0%0.0%
Profit before taxRs m14140685-79.1%-39.7%
TaxRs m108115-14-111.7%-112.5%
Profit after taxRs m3229198-66.2%204.9%
Gross profit margin%10.119.03.3
Effective tax rate%77.128.3-15.9
Net profit margin%2.113.35.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 26.3% on a year-on-year (YoY) basis. The expenses were up by 35.8% YoY during the same period.
  • The company's operating profit declined by 58.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 3.3% in 4QFY19 as against 10.1% in 4QFY18.
  • Depreciation charges increased by 10.1% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 157.1% YoY during the quarter.
  • Net profit for the quarter increased by 204.9% YoY. Net profit margins during the quarter increased from 2.1% in 4QFY18 to 5.0% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 11.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 5.5% QoQ during the same period.
  • The company's operating profit declined by 84.4% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 3.3% in 4QFY19 as against 19.0% in 3QFY18.
  • Net profit for the quarter declined by 66.2% QoQ, while net profit margins declined from 13.3% in 3QFY18 to 5.0% in 4QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,194.6 to Rs 2,089.9, registering a Gain of Rs 895.4 or around 75.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,392.0 (down 0.0%). Over the last one year it has moved up from 13,044.2 to 13,392.0, a gain of 348 points (up 2.7%).

Overall, the S&P BSE SENSEX is up 14.3% over the year.

Current Valuations

At the current price of Rs 2,089.9, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 96.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 21.2 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 291 m (up 381.0% YoY). Sales on the other hand came in at Rs 2 bn (up 67.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 91 m (down 66.7% YoY). Sales on the other hand came in at Rs 2 bn (down 1.8% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Jul 19, 2019 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - ADCOCK INGRAM COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS